|
Sol-Gel Technologies Ltd. (SLGL) DCF-Bewertung
IL | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Sol-Gel Technologies Ltd. (SLGL) Bundle
Gewinnen Sie Einblick in Ihre SLGL-Bewertungsanalyse (Sol-Gel Technologies Ltd. (SLGL) mit unserem DCF-Taschenrechner des hochmodernen DCF! Mit realer (SLGL-) Daten können Sie mit dieser Excel-Vorlage Prognosen und Annahmen anpassen, um den inneren Wert von Sol-Gel Technologies Ltd. (SLGL) genau zu bestimmen.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 22.9 | 8.8 | 31.3 | 3.9 | 1.6 | 1.1 | .8 | .6 | .4 | .3 |
| Revenue Growth, % | 0 | -61.71 | 256.54 | -87.58 | -59.98 | -27.32 | -27.32 | -27.32 | -27.32 | -27.32 |
| EBITDA | -25.1 | -29.3 | 3.8 | -15.7 | -29.0 | -.9 | -.6 | -.5 | -.3 | -.2 |
| EBITDA, % | -109.43 | -333.91 | 12.29 | -403.86 | -1863.77 | -77.54 | -77.54 | -77.54 | -77.54 | -77.54 |
| Depreciation | .9 | .9 | .9 | .6 | .3 | .1 | .1 | .1 | .0 | .0 |
| Depreciation, % | 3.87 | 10.79 | 2.81 | 14.47 | 22.01 | 10.79 | 10.79 | 10.79 | 10.79 | 10.79 |
| EBIT | -26.0 | -30.2 | 3.0 | -16.2 | -29.3 | -.9 | -.6 | -.5 | -.3 | -.2 |
| EBIT, % | -113.3 | -344.69 | 9.48 | -418.34 | -1885.78 | -78.1 | -78.1 | -78.1 | -78.1 | -78.1 |
| Total Cash | 50.4 | 50.2 | 43.2 | 33.6 | 38.0 | 1.1 | .8 | .6 | .4 | .3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 4.1 | 2.2 | 13.1 | 7.9 | .4 | .5 | .3 | .2 | .2 | .1 |
| Account Receivables, % | 17.99 | 24.55 | 41.78 | 202.37 | 24.26 | 41.71 | 41.71 | 41.71 | 41.71 | 41.71 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0.00000436605 | 0 | 0.000003197749 | 0.000025753284 | 0 | 0.000006663416 | 0.000006663416 | 0.000006663416 | 0.000006663416 | 0.000006663416 |
| Accounts Payable | 1.7 | 1.2 | .8 | .3 | .2 | .1 | .1 | .0 | .0 | .0 |
| Accounts Payable, % | 7.47 | 13.72 | 2.45 | 6.46 | 9.91 | 8 | 8 | 8 | 8 | 8 |
| Capital Expenditure | -.6 | -.4 | -.1 | -.2 | -.1 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | -2.61 | -5.12 | -0.45728 | -4.4 | -8.62 | -4.24 | -4.24 | -4.24 | -4.24 | -4.24 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -26.0 | -28.3 | 4.0 | -14.8 | -29.3 | -.9 | -.6 | -.5 | -.3 | -.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -28.1 | -26.3 | -6.6 | -9.7 | -21.7 | -.9 | -.5 | -.3 | -.2 | -.2 |
| WACC, % | 9.71 | 9.69 | 9.71 | 9.68 | 9.71 | 9.7 | 9.7 | 9.7 | 9.7 | 9.7 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1.8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | -2 | |||||||||
| Present Terminal Value | -1 | |||||||||
| Enterprise Value | -3 | |||||||||
| Net Debt | -6 | |||||||||
| Equity Value | 3 | |||||||||
| Diluted Shares Outstanding, MM | 27 | |||||||||
| Equity Value Per Share | 0.10 |
What You Will Get
- Real SLGL Financial Data: Pre-filled with Sol-Gel Technologies' historical and projected data for precise analysis.
- Fully Editable Template: Easily modify key inputs such as revenue growth, WACC, and EBITDA %.
- Automatic Calculations: Instantly see Sol-Gel Technologies' intrinsic value update based on your adjustments.
- Professional Valuation Tool: Tailored for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: A straightforward layout and clear instructions suitable for all experience levels.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Sol-Gel Technologies Ltd. (SLGL).
- WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable inputs specific to SLGL.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates as per Sol-Gel's financial outlook.
- Integrated Financial Ratios: Assess profitability, leverage, and efficiency ratios relevant to Sol-Gel Technologies Ltd. (SLGL).
- Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis.
How It Works
- Step 1: Download the prebuilt Excel template featuring Sol-Gel Technologies Ltd. (SLGL) data.
- Step 2: Navigate through the pre-filled sheets to familiarize yourself with the critical metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see the recalculated results, including Sol-Gel Technologies Ltd.'s (SLGL) intrinsic value.
- Step 5: Make well-informed investment choices or create reports based on the generated outputs.
Why Choose This Calculator for Sol-Gel Technologies Ltd. (SLGL)?
- Accurate Data: Utilize real financials from Sol-Gel Technologies to ensure dependable valuation outcomes.
- Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Built-in calculations save you the hassle of starting from the ground up.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotech sector.
- User-Friendly: Designed with an intuitive interface and clear instructions for users of all experience levels.
Who Should Use This Product?
- Biotechnology Students: Explore drug development processes and apply them to real-world scenarios.
- Researchers: Utilize advanced models in your studies on pharmaceutical innovations.
- Investors: Evaluate your investment strategies and analyze the market performance of Sol-Gel Technologies Ltd. (SLGL).
- Market Analysts: Enhance your analysis with a customizable framework for assessing biotech companies.
- Healthcare Entrepreneurs: Understand the evaluation methods used for assessing biotech firms like Sol-Gel Technologies Ltd. (SLGL).
What the Template Contains
- Historical Data: Contains Sol-Gel Technologies Ltd.'s (SLGL) previous financials and foundational forecasts.
- DCF and Levered DCF Models: Comprehensive templates for calculating Sol-Gel's intrinsic value.
- WACC Sheet: Pre-configured calculations for Weighted Average Cost of Capital.
- Editable Inputs: Adjust key drivers such as growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: An extensive breakdown of Sol-Gel Technologies Ltd.'s (SLGL) financials.
- Interactive Dashboard: Dynamically visualize valuation results and projections.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.